These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9383179)

  • 1. Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans.
    Ohishi M; Ueda M; Rakugi H; Naruko T; Kojima A; Okamura A; Higaki J; Ogihara T
    J Hypertens; 1997 Nov; 15(11):1295-302. PubMed ID: 9383179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions.
    Ohishi M; Ueda M; Rakugi H; Naruko T; Kojima A; Okamura A; Higaki J; Ogihara T
    J Hypertens; 1999 Apr; 17(4):547-53. PubMed ID: 10404957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plaque progression and destabilization in human coronary arteries].
    Komatsu R; Ueda M
    Nihon Rinsho; 1998 Oct; 56(10):2477-82. PubMed ID: 9796305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions.
    Haberbosch W; Bohle RM; Franke FE; Danilov S; Alhenc-Gelas F; Braun-Dullaeus R; Hölschermann H; Waas W; Tillmanns H; Gardemann A
    Atherosclerosis; 1997 Apr; 130(1-2):203-13. PubMed ID: 9126666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis.
    Fukuhara M; Geary RL; Diz DI; Gallagher PE; Wilson JA; Glazier SS; Dean RH; Ferrario CM
    Hypertension; 2000 Jan; 35(1 Pt 2):353-9. PubMed ID: 10642324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans.
    Ohishi M; Ueda M; Rakugi H; Okamura A; Naruko T; Becker AE; Hiwada K; Kamitani A; Kamide K; Higaki J; Ogihara T
    Circulation; 1997 Nov; 96(10):3328-37. PubMed ID: 9396424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques.
    Morioka M; Hamada J; Hashiguchi A; Hasegawa Y; Todaka T; Yano S; Kai Y; Miura M; Fujioka S; Ushio Y
    Surg Neurol; 2004 Oct; 62(4):292-301; discussion 301-3. PubMed ID: 15451269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
    Prasad A; Husain S; Quyyumi AA
    J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.
    Diet F; Pratt RE; Berry GJ; Momose N; Gibbons GH; Dzau VJ
    Circulation; 1996 Dec; 94(11):2756-67. PubMed ID: 8941100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
    van der Wal AC; Becker AE; van der Loos CM; Das PK
    Circulation; 1994 Jan; 89(1):36-44. PubMed ID: 8281670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis.
    Hai E; Ikura Y; Naruko T; Shirai N; Yoshimi N; Kayo S; Sugama Y; Fujino H; Ohsawa M; Tanzawa K; Yokota T; Ueda M
    Int J Mol Med; 2004 May; 13(5):649-54. PubMed ID: 15067364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.
    Schieffer B; Schieffer E; Hilfiker-Kleiner D; Hilfiker A; Kovanen PT; Kaartinen M; Nussberger J; Harringer W; Drexler H
    Circulation; 2000 Mar; 101(12):1372-8. PubMed ID: 10736279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis.
    Kolodgie FD; Burke AP; Skorija KS; Ladich E; Kutys R; Makuria AT; Virmani R
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2523-9. PubMed ID: 16960105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome.
    Hoshida S; Kato J; Nishino M; Egami Y; Takeda T; Kawabata M; Tanouchi J; Yamada Y; Kamada T
    Circulation; 2001 Feb; 103(5):630-3. PubMed ID: 11156871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.
    Chen X; Howatt DA; Balakrishnan A; Moorleghen JJ; Wu C; Cassis LA; Daugherty A; Lu H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1085-9. PubMed ID: 27055902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis.
    Minamino T; Kurihara H; Takahashi M; Shimada K; Maemura K; Oda H; Ishikawa T; Uchiyama T; Tanzawa K; Yazaki Y
    Circulation; 1997 Jan; 95(1):221-30. PubMed ID: 8994440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression and co-localization of ACE, angiotensin II AT(1) receptors and inducible nitric oxide synthase in atherosclerotic human coronary arteries.
    Ohishi M; Dusting GJ; Fennessy PA; Mendelsohn FA; Li XC; Zhuo JL
    Int J Physiol Pathophysiol Pharmacol; 2010 Apr; 2(2):111-24. PubMed ID: 21179388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques.
    Ribichini F; Pugno F; Ferrero V; Bussolati G; Feola M; Russo P; Di Mario C; Colombo A; Vassanelli C
    J Am Coll Cardiol; 2006 Mar; 47(6):1143-9. PubMed ID: 16545643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, localisation and function of ACE and chymase in normal and atherosclerotic human coronary arteries.
    Borland JA; Kelsall C; Yacoub MH; Chester AH
    Vascul Pharmacol; 2005 Feb; 42(3):99-108. PubMed ID: 15792927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
    Ferrari R; Guardigli G; Ceconi C
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):331-9. PubMed ID: 20577898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.